News

For the most up to date news, please follow us on LinkedIn via the link below

LinkedIn

Download the White Paper on “How freeze-drying fits in the paradigm shift from batch to continuous manufacturing”

Coriolis Pharma extends its service portfolio by integrating RheaVita’s single vial unit (SVU) technology for continuous and controlled freeze-drying to stabilize novel modalities as part of biologics drug product development for clients.

Read More

Download the White Paper on “Stabilizing mRNA LNPs via controlled, continuous freeze-drying”

Coriolis Pharma extends its service portfolio by integrating RheaVita’s single vial unit (SVU) technology for continuous and controlled freeze-drying to stabilize novel modalities as part of biologics drug product development for clients.

Read More

Coriolis Pharma and RheaVita join forces in collaboration for continuous and controlled freeze-drying technology

Coriolis Pharma extends its service portfolio by integrating RheaVita’s single vial unit (SVU) technology for continuous and controlled freeze-drying to stabilize novel modalities as part of biologics drug product development for clients.

Read More

Continuous freeze-drying of mRNA LNPs enables storage at higher temperatures

Research at Ghent University, in collaboration with The University of British Columbia, has shown that continuous freeze-drying of mRNA LNPs enables long-term storage at higher temperatures for months without losing their transfection properties

Read More

Advanced Therapies – March 14 – 15, 2023

On March 14 & 15 we attended the Advanced Therapies Congress in London where we presented a new poster on avoiding cold chain logistic challenges by using freeze-drying to stabilize gene therapies.

Read More

New poster publications available

Stay up to date with the latest scientific insights

Read More